Page 3 - Edwards Higher Standard Brochure PP--US-5551 v3.0
P. 3

SAPIEN 3 TAVR is built upon:
25,000+ 450,000+
patients studied in Edwards THV trials patients treated worldwide with Edwards TAVR valves
       You asked.
TAVR in 2007
We answered.
TAVR today
Save lives, starting with the sickest patients
Extend lifesaving treatment to even more
Reset the bar to be even better than surgery
Continue to meet the emerging needs of new patient populations
                   SAPIEN valve
Introducing TAVR as a lifesaving treatment option for patients who are inoperable or at high risk for surgery
Non-inferior to surgery on mortality and stroke in intermediate-risk patients
SAPIEN 3 valve
The only THV proven superior* to surgery for low-risk patients
SAPIEN 3 Ultra valve
Further reducing paravalvular leak (PVL) and reaching new patients with expanded indications
*On the primary endpoint of death, stroke, and rehospitalization at 1 year

   1   2   3   4   5